TSX
CA$18.53
CA$18.53

Overview

Price performance
Low
CA$18.24
High
CA$18.69
Market open. Last updated: Nov 4, 2026, 6:24 PM UTC
CA$
18.53
1.08 (6.19%)
Average, 50 days
CA$17.61
CA$18.63
Open
CA$18.46
Previous close
CA$17.45
52-week high
CA$27.58
Jan 16, 2026 (10 months ago)
52-week low
CA$14.88
Mar 20, 2026 (8 months ago)
24.53%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
62.00B
Volume
68 552
Total Return (3M)
0.49%
Total Return (1Y)
-3.09%
—
Sector
Healthcare
Links
Tags
Healthcare
Drug Manufacturers - General
TSX
DK
About
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.